Company Overview
Welcome to Aces Diagnostics, where we aim to revolutionize testing for Lyme disease.
Founded in 2016 on the principles of precision and innovation, Aces Diagnostics was created to improve the accuracy of diagnostic testing, increase accessibility to tests, and improve clinical outcomes for patients with Lyme disease and other tick borne illnesses.
We are a team of experts with over 50 years combined experience in all aspects of Lyme disease – research, clinical, diagnostics, and the patient experience.
Join us as we strive to bring better testing through the commercialization of our >90% accurate test, LYMESEEK™
Our committed team
Advisors
Brian Fallon, MD MPH
Director of the Center for
Neuroinflammatory
Disorders and Biobehavioral
Medicine
Director of Lyme and Tick-borne
Diseases Research University at
Columbia University
Head of the Clinical Trials
Network (CTNCC)
Mark Soloski, PhD
Emeritus Professor, Johns
Hopkins University School
of Medicine
Senior Advisor for the Johns
Hopkins Lyme Disease Research
Center. Research whose
research includes investigation
of the human immune response
to Borrelia infection using
genomic, proteomic and
immune phenotype to identify
cellular or molecular immune
biomarkers
Holiday Goodreau
Executive Director
LivLyme Foundation
Chair of four global scientific
summits for tick-borne diseases,
collaborating with eminent
doctors, scientists, and activists
from around the world. Co-chair
of the HHS Tick Borne Disease
Working Group
Richard Horowitz, MD
Medical Director
Hudson Valley Healing Arts
Center
Physician who has treated more
than 13,000 patients with Lyme
disease or other TBDs.
Researcher and author of peerreviewed articles on treatment of
Lyme disease patients. Co-chair
of the HHS Tick Borne Disease
Working Group
Our personal experience
Aces Diagnostics was established in 2017, to address an urgent and unmet need in the medical world for an accurate and accessible diagnostic test for Lyme disease. Our founder’s collective personal experiences of having to watch their daughters struggle for years with disabling symptoms that might have been prevented if there was an accurate diagnostic test was the motivation – to give doctors the tool they needed to diagnose patients and initiate prompt treatment.
